David Thomas Kuninger, PhD
Dr. David Kuninger leads research, development and commercialization of media systems for stem cell culture & differentiation, neurobiology, and cell therapy applications at Thermo Fisher Scientific as part of the Cell Biology business based in Frederick MD.
His teams support numerous portfolios and have launched over 25 new products over the past 3 years. David is a seasoned scientist and manager, experienced in media formulation & optimization, assay design and implementation, and troubleshooting. Expertise in cGMP compliance, spanning design, transfer and scale up, as well as verification and validation processes. Prior to starting at Thermo Fisher Scientific (legacy Invitrogen) in 2007 as Staff Scientist, he joined Oregon Health Sciences University as a Postdoctoral Fellow investigating the actions of insulin-like growth factors in the lab of Dr. Peter Rotwein, subsequently joining the faculty in the Department of Biochemistry at OHSU as a Research Instructor. He completed is PhD in Biochemistry and Genetics at the University of Texas Medical Branch in the laboratory of Dr. John Papaconstatinou and has a B.S. in Chemistry from the University of Oregon.